Description
The researcher will investigate the molecular mechanisms and organelle pathology of lysosomal and related neurodegenerative diseases, using multi-omics, genetic and pharmacological perturbations, patient-derived fibroblasts, iPSC models, and high-throughput drug-screening assays. The role also involves developing and automating assays, evaluating therapeutic candidates, collaborating across the Göttingen research network, and publishing reproducible results.
